These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 15094752)

  • 1. Treatment and unmet needs in steroid-refractory acute graft-versus-host disease.
    Malard F; Huang XJ; Sim JPY
    Leukemia; 2020 May; 34(5):1229-1240. PubMed ID: 32242050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of blood biomarkers in steroid-refractory or steroid-dependent acute graft-versus-host disease: a REACH2 analysis.
    Socié G; Niederwieser D; von Bubnoff N; Mohty M; Szer J; Or R; Garrett J; Prahallad A; Wilke C; Zeiser R
    Blood; 2023 Jun; 141(22):2771-2779. PubMed ID: 36827620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alemtuzumab treatment for steroid-refractory acute graft-versus-host disease leads to severe immunosuppression but not to relapse of malignant disease.
    Philippen L; Schub N; Günther A; Cario G; Schrappe M; Repp R; Gramatzki M
    Bone Marrow Transplant; 2024 Jan; 59(1):153-155. PubMed ID: 37932418
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid tapering after GVHD Rx: not too fast, not too slow.
    Martin PJ
    Blood Adv; 2024 Apr; 8(8):2044-2046. PubMed ID: 38652484
    [No Abstract]   [Full Text] [Related]  

  • 5. Regional intra-arterial steroid treatment in 120 patients with steroid-resistant or -dependent GvHD.
    Shapira MY; Klimov A; Vipul S; Grisariu S; Avni BR; Or R; Bloom AI
    Bone Marrow Transplant; 2017 Oct; 52(10):1416-1422. PubMed ID: 28650453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramesenteric steroid treatment for steroid- refractory gastrointestinal graft versus host disease.
    Bilgin AU; Topcuoğlu P; Sancak T; Konuk N; Arat M
    Turk J Haematol; 2012 Dec; 29(4):409-12. PubMed ID: 24385731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of rituximab in chronic graft-versus-host disease.
    Bates JS; Engemann AM; Hammond JM
    Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative approaches to treat steroid-resistant or steroid refractory GVHD.
    Berger M; Biasin E; Saglio F; Fagioli F
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S101-5. PubMed ID: 18978736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
    Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.
    Kobbe G; Schneider P; Rohr U; Fenk R; Neumann F; Aivado M; Dietze L; Kronenwett R; Hünerlitürkoglu A; Haas R
    Bone Marrow Transplant; 2001 Jul; 28(1):47-9. PubMed ID: 11498743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin.
    Khoury H; Kashyap A; Adkins DR; Brown RA; Miller G; Vij R; Westervelt P; Trinkaus K; Goodnough LT; Hayashi RJ; Parker P; Forman SJ; DiPersio JF
    Bone Marrow Transplant; 2001 May; 27(10):1059-64. PubMed ID: 11438821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-arterial catheter guided steroid administration for the treatment of steroid-refractory intestinal GvHD.
    Bürgler D; Medinger M; Passweg J; Fischmann A; Bucher C
    Leuk Res; 2014 Feb; 38(2):184-7. PubMed ID: 24268317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
    Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
    Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial steroid-injection therapy for steroid-refractory acute graft-versus-host disease with the evaluation of angiography.
    Nakai K; Tajima K; Tanigawa N; Matsumoto N; Zen K; Nomura S; Fujimoto M; Kishimoto Y; Amakawa R; Sawada S; Fukuhara S
    Bone Marrow Transplant; 2004 Jun; 33(12):1231-3. PubMed ID: 15094752
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.